Anti-rheumatic drugs.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012460:Sulfasalazine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents; D007978:Levamisole; D012460:Sulfasalazine; D006046:Gold; D003622:Dapsone; D010396:Penicillamine